CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced that Joseph Tucker, Ph.D., Chief Executive Officer, will participate in the Benzinga Psychedelics Capital Conference being held Thursday, April 13, 2023, at the Fontainebleau Miami Beach, Florida. Details of Enveric’s particip
The informative cannabis social network. Join groups, make friends and be part of the cannabis community! Share your recipes, product & strain reviews, tutorials and more! Log in or register to continue
Stock Ticker
- Loading stock data...
Categories
Recent Posts
- Nature Medicine Publishes Discovery of New Pharmacological Class by Aelis Farma, Phase 2a Study of First Drug Candidate for Cannabis Use Disorder
- Flora Growth Corp. to Effect Reverse Stock Split
- Canopy Growth Investors: July 24, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
- Rapid Dose Announces Proposed Private Placement Financing
- Can-Fite to Participate in Out-licensing and Distribution Partnering Meetings at Bio International Convention in Boston
More from this user
